Ozmosi | Medazepam Drug Profile
Drug Search Results
Using advanced filters...
Advanced Search [+]

Medazepam

Alternative Names: medazepam
Clinical Status: Inactive
Latest Update: 2024-02-22
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: GABA Modulator

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: *

Approval Status: Not Approved

Approved Countries: Chile | Colombia | Czech | Dominican Republic | Germany | Hungary | Ireland | Italy | Lithuania | Pakistan | Poland | Portugal | Romania | Russia | Slovakia | Slovenia | Spain | Taiwan | Turkey | Venezuela

Approved Indications: None

Known Adverse Events: None

Company: CM Chungmu Hospital
Company Location:
Company Founding Year: None
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Recent & Upcoming Milestones

Highest Development Phases

Trial ID

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Latest Trial Update Date

Data Updated